The MLC project continues its confident progress toward its global goal.
We have recently received the supporting documentation and are delighted to announce that the Flystat trademark for our CGM system has been officially registered in the United Arab Emirates.
https://mail-cdn.mlc.health/sert/05_translation_Certificate.pdf
https://mail-cdn.mlc.health/sert/09_translation_Certificate.pdf
https://mail-cdn.mlc.health/sert/10_translation_Certificate.pdf
https://mail-cdn.mlc.health/sert/42_translation_Certificate.pdf
https://mail-cdn.mlc.health/sert/44_translation_Certificate.pdf
https://mail-cdn.mlc.health/sert/Certificate_No_475675.pdf
https://mail-cdn.mlc.health/sert/Certificate_No_475676.pdf
https://mail-cdn.mlc.health/sert/Certificate_No_475677.pdf
https://mail-cdn.mlc.health/sert/Certificate_No_475678.pdf
https://mail-cdn.mlc.health/sert/Certificate_No_475679.pdf
This marks a significant step forward for MLC as it prepares to enter the market with its own continuous glucose monitoring system.
Flystat: the name under which our product will secure its rightful place on the global map of medical innovations.
From now on, this exact name, CGM Flystat, will be officially used across all communications, in marketing materials, at exhibitions, and in all interactions with investors and partners, replacing the former working name of our device, Fly.
Congratulations to everyone involved in the project!
